Skip to main content
. 2023 May 22;177(7):710–717. doi: 10.1001/jamapediatrics.2023.1440

Figure. Vaccine Doses Administered Among Recipients Aged 5 to 17 Years With Data From the CVS Health, HealthCore, and Optum Databases.

Figure.

The study start date was the earliest Emergency Use Authorization date for the BNT162b2 vaccination for each age group: for ages 5 to 11 years, October 29, 2021; ages 12 to 15 years, May 10, 2021; and ages 16 to 17 years, December 11, 2020. For the data cut dates, CVS Health data were available through May 31, 2022; HealthCore data through May 6, 2022; and Optum data through June 25, 2022.